Soy Isoflavones Market Report

To learn more about this report, Download Free Sample Report

Global Soy Isoflavones Market Size

The global soy isoflavones market size was valued at USD 1.49 billion in 2025 and is expected to reach USD 2.36 billion by 2034 from USD 1.57 billion in 2026. The market's promising CAGR for the predicted period is 5.20%.

Isoflavones are phytoestrogens and have a similar chemical structure to the hormone estrogen. Isoflavones can have estrogen-like or anti-estrogen effects and are considered SERMs (Selective Estrogen Receptor Modulators). Soy isoflavones are a rich source of estrogen and vitamin E and have properties as suppressants and antioxidants of breast cancer cells. They are extracted from the seed, leaves, bark, and husk of the soy plant, and the end products of soy isoflavones are available in powder, oil, or wax form. The growing awareness of the consumption of soy isoflavones in the diet and its benefits as the prevention and cure of heart disease, asthma, diabetes and multiple cancers are the main factors driving demand for soy isoflavones worldwide.

MARKET DRIVERS

The global soy isoflavones market has witnessed tremendous growth because of the wider applications in food and beverage, pharmaceuticals, nutraceuticals, etc. Growing consumer awareness of the health benefits associated with soy isoflavones, such as the prevention of heart disease, asthma, diabetes, and others, is further influencing this market. In addition to this, the growing trend of plant-based diets due to their benefits, such as weight control, hypoglycemia, cholesterol and abdominal fat, is expected to drive the growth of the market for soy isoflavones in the years to come. Consuming soy isoflavones in foods and dietary supplements also reduces the risk of breast cancer and cancer cell growth by reducing the process of cell mitosis, increasing the industry demand for soy isoflavones in foods and beverages and has become the driving force behind the global soy isoflavones market. The growing demand for soy isoflavones from the cosmetic industry to treat skin tightening, and wrinkles, protect against sun damage and hydrate the skin, also boosting the global market for soy isoflavones.

MARKET RESTRAINTS

However, excessive consumption of soy isoflavones produces side effects such as food allergies, migraines, and thyroid disorders and can hamper the use of soy isoflavones and restrict the global market. Also, climate changes can hamper the cultivation of soy plants, which could further affect the growth of the soy isoflavones market. Besides, with the constant growth of the food industry, market players have opportunities to invest in this market.

REPORT COVERAGE

REGIONAL ANALYSIS

North America dominates and has contributed to the major shares of the global soy isoflavone market in terms of revenue and volume due to the knowledge and use of soy isoflavones in food and medicine

Asia Pacific is the most lucrative market for soy isoflavones and is expected to record the largest shares in terms of revenue and volume during the forecast period due to the increased use of soy isoflavones in pharmaceutical drugs.

Europe has also contributed to a significant share of the global soy isoflavones market, followed by North America and is expected to record a significant growth rate over the forecast period.

Latin America and Japan are expected to show healthy growth in the global soy isoflavone market during the forecast period.

Middle East and Africa are at their early stage in the global market and is foreseen to record a notable growth rate owing to increasing consumer awareness about the benefits of soy isoflavones during the outlook period 2020 to 2025.

KEY PLAYERS IN THE GLOBAL SOY ISOFLAVONES MARKET

Key Players Soy Isoflavones Market Are E. I. du Pont de Nemours and Company, Frutarom Health (SoyLife), Novogen Limited, Cargill Inc, BASF SE, SunOpta Inc, Koninklijke DSM N.V.  (DSM), Archer Daniels Midland Company (ADM) etc.

RECENT HAPPENINGS IN THE MARKET

Archer Daniels Midland Company acquired Global Soy Isoflavone from The Solae Company, which includes a broad portfolio of U.S. patents, numerous foreign equivalents and pending applications. As part of the acquisition, Solae will discontinue the activity of soy isoflavones. ADM now provides Novasoy (R) soy isoflavones to the existing Solae customers to offer a transition.

MARKET SEGMENTATION

This research report on the global soy isoflavones market has been segmented and sub-segmented based on raw material, product type, application & region.      

 By Application

• Cosmetics
• Nutraceuticals
• Food And Beverages

By Raw Material

• Non-Genetically Modified 
• Genetically Modified

By Product Type

• Gluten
• Daidzein
• Genistein
• Nutraceuticals 

By Region

• North America
• Europe
• The Asia Pacific
• Latin America
• Middle East and Africa